6505--Melatonin Tablets

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36E79726R0015
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center is soliciting proposals for the procurement of melatonin tablets and capsules in 1mg, 3mg, and 5mg strengths under the VA and DoD Pharmaceutical Prime Vendor Programs. The solicitation requires offerors to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique 11-digit National Drug Code (NDC) or Universal Product Code (UPC) numbers for each offered product. All products must be compatible with automated dispensing units, packaged in non-glass bottles with child-proof safety caps, properly labeled, and include GS1-128 or HIBCC barcode labeling meeting specified quality standards. Manufacturing facilities must maintain current FDA cGMP acceptable status, and contractors must comply with Drug Supply Chain Security Act (DSCSA) requirements including NABP Trading Partner Directory registration. The original proposal deadline of March 26, 2026, has been extended to April 9, 2026, at 2:30 PM Central Time, and offerors must acknowledge receipt of the amendment prior to submission or face potential rejection.

This procurement carries no set-aside designation and will result in a single award in the aggregate covering a one-year base ordering period plus four one-year pre-priced option periods. The base year estimated annual requirements total 1,837,689 bottles across all strengths and package sizes (60 and 90 count), with the contract serving VA facilities, DoD ordering activities, Indian Health Service, Bureau of Prisons, Captain James A. Lovell Federal Health Care Center, and participating Option 2 State Veteran Homes. Non-small business concerns valued over $900,000 must submit an approved small business subcontracting plan. The awarded contractor must establish business-to-business agreements with PPV contractors within an implementation period not to exceed 60 days and submit quarterly sales reports with Cost Recovery Fees within 30 days of each quarter's end. Performance will occur at the contractor's manufacturing and distribution facilities supporting all participating federal healthcare entities nationwide.

Notice text

N/A

Files

File Type Posted
36E79726R0015 0001.docx DOCX document
36E79726R0015.docx DOCX document

Notice history

Notice Type Posted
6505--Melatonin Tablets Effective 09/15/26 - 09/14/27 Award Award Notice
This notice Latest solicitation Solicitation
6505--Melatonin Tablets Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside
6505--Sodium Bicarbonate Injection Vial Restricted to Made in America NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity